CD40 expression on human pancreatic duct cells: role in nuclear factor-kappa B activation and production of pro-inflammatory cytokines

[1]  Y. Kotake,et al.  Free radicals and the pathogenesis of type 1 diabetes: beta-cell cytokine-mediated free radical generation via cyclooxygenase-2. , 2003, Diabetes.

[2]  R. Gomis,et al.  Evidence of expression of endotoxin receptors CD14, toll‐like receptors TLR4 and TLR2 and associated molecule MD‐2 and of sensitivity to endotoxin (LPS) in islet beta cells , 2003, Clinical and experimental immunology.

[3]  O. Korsgren,et al.  Characterization of endocrine progenitor cells and critical factors for their differentiation in human adult pancreatic cell culture. , 2003, Diabetes.

[4]  N. Kleiman,et al.  Soluble CD40 ligand in acute coronary syndromes. , 2003, The New England journal of medicine.

[5]  I. Rooman,et al.  Netrin-1 expression in fetal and regenerating rat pancreas and its effect on the migration of human pancreatic duct and porcine islet precursor cells , 2003, Diabetologia.

[6]  V. Lefebvre,et al.  Formation of insulin-positive cells in implants of human pancreatic duct cell preparations from young donors , 2003, Diabetologia.

[7]  T. van der Poll,et al.  Immune monitoring in whole blood using real-time PCR. , 2003, Journal of immunological methods.

[8]  R. Flavell,et al.  TNF‐α impairs peripheral tolerance towards β‐cells, and local costimulation by B7.1 enhances the effector function of diabetogenic T cells , 2003 .

[9]  J. Freedman.  CD40 ligand--assessing risk instead of damage? , 2003, The New England journal of medicine.

[10]  D. Greiner,et al.  Blockade of CD40-Mediated Signaling Is Sufficient for Inducing Islet But Not Skin Transplantation Tolerance 1 , 2003, The Journal of Immunology.

[11]  C. Benjamin,et al.  Prevention of autoimmune diabetes in the DRBB rat by CD40/154 blockade. , 2002, Journal of autoimmunity.

[12]  M. Goldman,et al.  Critical role of protein kinase C ϵ for lipopolysaccharide‐induced IL‐12 synthesis in monocyte‐derived dendritic cells , 2002, European journal of immunology.

[13]  S. M. Propst,et al.  CD40-mediated Activation of NF-κB in Airway Epithelial Cells* , 2002, The Journal of Biological Chemistry.

[14]  M. Daha,et al.  Production of inflammatory mediators by renal epithelial cells is insensitive to glucocorticoids , 2002, British journal of pharmacology.

[15]  Ranjeny Thomas,et al.  CD40 Ligation Conditions Dendritic Cell Antigen-Presenting Function Through Sustained Activation of NF-κB1 , 2002, The Journal of Immunology.

[16]  P. Matzinger.  The Danger Model: A Renewed Sense of Self , 2002, Science.

[17]  S. Peyrol,et al.  In vitro expression of fas and CD40 and induction of apoptosis in human cystic fibrosis airway epithelial cells. , 2002, Respiratory medicine.

[18]  M. Goldman,et al.  Analysis of spontaneous mRNA cytokine production in peripheral blood. , 2002, Journal of immunological methods.

[19]  M. V. von Herrath,et al.  CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells. , 2002, Immunity.

[20]  J. Corbett,et al.  Interleukin-1 Plus γ-Interferon-Induced Pancreatic β-Cell Dysfunction Is Mediated by β-Cell Nitric Oxide Production , 2002 .

[21]  D. Adams,et al.  CD40 activation‐induced, Fas‐dependent apoptosis and NF‐κB/AP‐1 signaling in human intrahepatic biliary epithelial cells , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  R. Flavell,et al.  A Dual Role for TNF-α in Type 1 Diabetes: Islet-Specific Expression Abrogates the Ongoing Autoimmune Process When Induced Late but Not Early During Pathogenesis1 , 2001, The Journal of Immunology.

[23]  D. Pipeleers,et al.  Distinction between interleukin-1-induced necrosis and apoptosis of islet cells. , 2001, Diabetes.

[24]  P. Matzinger,et al.  Danger signals: SOS to the immune system. , 2001, Current opinion in immunology.

[25]  L. Bouwens,et al.  Role of pancreatic beta-cells in the process of beta-cell death. , 2001, Diabetes.

[26]  C. Benjamin,et al.  Anti-CD154 (CD40L) prevents recurrence of diabetes in islet isografts in the DR-BB rat. , 2000, Diabetes.

[27]  S. M. Propst,et al.  Proinflammatory and Th2-Derived Cytokines Modulate CD40-Mediated Expression of Inflammatory Mediators in Airway Epithelia: Implications for the Role of Epithelial CD40 in Airway Inflammation , 2000, The Journal of Immunology.

[28]  S. Bonner-Weir,et al.  In vitro cultivation of human islets from expanded ductal tissue. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R. Flavell,et al.  The temporal importance of TNFalpha expression in the development of diabetes. , 2000, Immunity.

[30]  D. Eizirik,et al.  Interleukin-1beta-induced alteration in a beta-cell phenotype can reduce cellular sensitivity to conditions that cause necrosis but not to cytokine-induced apoptosis. , 2000, Diabetes.

[31]  J. Banchereau,et al.  CD40‐CD40 ligand , 2000, Journal of leukocyte biology.

[32]  G. Burckart,et al.  Nuclear Factor Kappa B: Important Transcription Factor and Therapeutic Target , 1998, Journal of clinical pharmacology.

[33]  J. Corbett,et al.  IL-1 produced and released endogenously within human islets inhibits beta cell function. , 1998, The Journal of clinical investigation.

[34]  L. Bouwens,et al.  Extra-insular beta cells associated with ductules are frequent in adult human pancreas , 1998, Diabetologia.

[35]  K. Salmela,et al.  Implantation of standardized beta-cell grafts in a liver segment of IDDM patients: graft and recipient characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft , 1998, Diabetologia.

[36]  Reinhold Förster,et al.  CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells , 1998, Nature.

[37]  R. Rajotte,et al.  TNF-alpha down-regulates type 1 cytokines and prolongs survival of syngeneic islet grafts in nonobese diabetic mice. , 1997, Journal of immunology.

[38]  L. Bouwens,et al.  Effect of Interferon-γ and Glucose on Major Histocompatibility Complex Class I and Class II Expression by Pancreatic β- and Non-β-Cells1 , 1997 .

[39]  J. Banchereau,et al.  Functions of CD40 on B cells, dendritic cells and other cells. , 1997, Current opinion in immunology.

[40]  S. Ghosh,et al.  Rel/NF-?B and I?B proteins: an overview , 1997 .

[41]  D. Pipeleers,et al.  Prolonged exposure of human beta cells to elevated glucose levels results in sustained cellular activation leading to a loss of glucose regulation. , 1996, The Journal of clinical investigation.

[42]  C. Janeway,et al.  Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells , 1996, The Journal of experimental medicine.

[43]  R. Noelle,et al.  Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[44]  M. Mcdaniel,et al.  Intraislet release of interleukin 1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase , 1995, The Journal of experimental medicine.

[45]  I. Berberich,et al.  Cross-linking CD40 on B cells rapidly activates nuclear factor-kappa B. , 1994, Journal of immunology.

[46]  J. Banchereau,et al.  Activation of human dendritic cells through CD40 cross-linking , 1994, The Journal of experimental medicine.

[47]  R. Tisch,et al.  Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process , 1994, The Journal of experimental medicine.

[48]  L. Baxter,et al.  A Second Pathway for Regeneration of Adult Exocrine and Endocrine Pancreas: A Possible Recapitulation of Embryonic Development , 1993, Diabetes.

[49]  H. Mcdevitt,et al.  Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[50]  G. Nabel,et al.  Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[51]  D. Greiner,et al.  Sufficient for Inducing Islet But Not Skin Blockade of CD 40-Mediated Signaling Is , 2003 .

[52]  C. Janeway,et al.  Innate immune recognition. , 2002, Annual review of immunology.

[53]  Inder M Verma,et al.  NF-kappaB regulation in the immune system. , 2002, Nature reviews. Immunology.

[54]  J. Corbett,et al.  Interleukin-1 plus gamma-interferon-induced pancreatic beta-cell dysfunction is mediated by beta-cell nitric oxide production. , 2002, Diabetes.

[55]  S. M. Propst,et al.  CD40-mediated activation of NF-kappa B in airway epithelial cells. , 2002, The Journal of biological chemistry.

[56]  Peter Lipsky,et al.  Cytokines and autoimmunity , 2002, Nature Reviews Immunology.

[57]  L. Bouwens,et al.  Contribution of ductal cells to cytokine responses by human pancreatic islets. , 1999, Diabetes.

[58]  R. Flavell,et al.  CD40 and CD154 in cell-mediated immunity. , 1998, Annual review of immunology.

[59]  M. May,et al.  Rel/NF-kappa B and I kappa B proteins: an overview. , 1997, Seminars in cancer biology.

[60]  L. Bouwens,et al.  Effect of interferon-gamma and glucose on major histocompatibility complex class I and class II expression by pancreatic beta- and non-beta-cells. , 1997, The Journal of clinical endocrinology and metabolism.

[61]  A. Woltman,et al.  J Am Soc Nephrol 11: 2044–2055, 2000 Interleukin-17 and CD40-Ligand Synergistically Enhance Cytokine and Chemokine Production by Renal Epithelial Cells , 2022 .